Opioid growth factor and the treatment of human pancreatic cancer: A review

Por Zagon, Ian S, McLaughlin, Patricia J
Publicado em 2014

Topical Naltrexone as Treatment for Type 2 Diabetic Cutaneous Wounds

Por Immonen, Jessica A., Zagon, Ian S., McLaughlin, Patricia J.
Publicado em 2014

Featured Article: Nuclear export of opioid growth factor receptor is CRM1 dependent

Por Kren, Nancy P, Zagon, Ian S, McLaughlin, Patricia J
Publicado no Exp Biol Med (Maywood) (2015)

The Yin and Yang of the Opioid Growth Regulatory System: Focus on Diabetes—The Lorenz E. Zimmerman Tribute Lecture

Por Sassani, Joseph W., Mc Laughlin, Patricia J., Zagon, Ian S.
Publicado no J Diabetes Res (2016)

The OGF-OGFr axis utilizes the p21 pathway to restrict progression of human pancreatic cancer

Por Cheng, Fan, McLaughlin, Patricia J, Verderame, Michael F, Zagon, Ian S
Publicado em 2008

The OGF–OGFr Axis Utilizes the p16(INK4a) and p21(WAF1/CIP1) Pathways to Restrict Normal Cell Proliferation

Por Cheng, Fan, McLaughlin, Patricia J., Verderame, Michael F., Zagon, Ian S.
Publicado em 2009

Naltrexone and Insulin Are Independently Effective but Not Additive in Accelerating Corneal Epithelial Healing in Type I Diabetic Rats

Por Klocek, Matthew S., Sassani, Joseph W., McLaughlin, Patricia J., Zagon, Ian S.
Publicado em 2009

Diabetic Keratopathy and Treatment by Modulation of the Opioid Growth Factor (OGF) - OGF Receptor (OGFr) Axis With Naltrexone: A Review

Por McLaughlin, Patricia J., Sassani, Joseph W., Klocek, Matthew S., Zagon, Ian S.
Publicado em 2009

Topical Naltrexone Reverses Dry Eye and Restores Corneal Sensation in Diabetes Mellitus

Por Zagon, Ian S., Klocek, Matthew S., Sassani, Joseph W., McLaughlin, Patricia J.
Publicado em 2009

Internalization of the opioid growth factor, [Met(5)]-enkephalin, is dependent on clathrin-mediated endocytosis for downregulation of cell proliferation

Por Cheng, Fan, McLaughlin, Patricia J., Banks, William A., Zagon, Ian S.
Publicado em 2010

Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of...

Por Hammer, Leslie A, Waldner, Hanspeter, Zagon, Ian S, McLaughlin, Patricia J
Publicado no Exp Biol Med (Maywood) (2015)

Topical Application of Naltrexone Facilitates Reepithelialization of the Cornea in Diabetic Rabbits

Por Zagon, I. S., Sassani, Joseph W., Carroll, Melissa A., McLaughlin, Patricia J.
Publicado em 2009

Spontaneous Episodic Decreased Tear Secretion in Rats Is Related to Opioidergic Signaling Pathways

Por Zagon, Ian S., Campbell, Anna M., Sassani, Joseph W., McLaughlin, Patricia J.
Publicado em 2012

Endogenous opioid inhibition of proliferation of T and B cell subpopulations in response to immunization for experimental autoimmune encephalomyelitis

Por McLaughlin, Patricia J, McHugh, Daniel P, Magister, Marcus J, Zagon, Ian S
Publicado no BMC Immunol (2015)

Regulation of Tenon's Capsule Fibroblast Cell Proliferation by the Opioid Growth Factor and the Opioid Growth Factor Receptor Axis

Por Klocek, Matthew S., Sassani, Joseph W., Donahue, Renee N., McLaughlin, Patricia J., Zagon, Ian S.
Publicado em 2010

Growth inhibition of thyroid follicular cell-derived cancers by the opioid growth factor (OGF) - opioid growth factor receptor (OGFr) axis

Por McLaughlin, Patricia J, Zagon, Ian S, Park, Sunny S, Conway, Andrea, Donahue, Renee N, Goldenberg, David
Publicado em 2009

Naltrexone Prevents Exuberant Granulation Tissue and Neovascularization in the Rat Cornea

Por Zagon, Ian S., Klocek, Matthew S., Griffith, James W., Sassani, Joseph W., Komáromy, András M., McLaughlin, Patricia J.
Publicado em 2008

The opioid growth factor-opioid growth factor receptor axis regulates cell proliferation of human hepatocellular cancer

Por Avella, Diego M., Kimchi, Eric T., Donahue, Renee N., Tagaram, Hephzibah Rani S., McLaughlin, Patricia J., Zagon, Ian S., Staveley-O'Carroll, Kevin F.
Publicado em 2010

Multiple Sclerosis: Perspectives in Treatment and Pathogenesis

Publicado em 2017-11-08